Hardean Achneck
CIK: 0002037976
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALGS
Aligos Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Achneck Hardean
Achneck Hardean (SEC CIK 0002037976) files insider reports with the SEC as Chief Medical Officer of Aligos Therapeutics, Inc. (ALGS).
Signal8 holds 2 ownership filings by Achneck Hardean (1 Form 3, 1 Form 4), filed between Sep 26, 2024 and Oct 10, 2024. Those filings report 1 transaction, the latest on Oct 8, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Achneck Hardean's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Achneck Hardean
- Oct 8, 2024: Grant or award of ALGS derivative securities (Form 4, code A).
Other insiders filing for Aligos Therapeutics, Inc. (ALGS)
- Preston Heather, Director
- Chavez Margarita, Director
- Martell Bridget A, Director
- Scopa James Paul, Director
- Nuechterlein Carole, Director
- Hirth Peter, Director